Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Active not recruiting 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 6Leukemia, Myeloid, Acute 4Thyroid Neoplasms 2Neoplasms 2Hepatoblastoma 2Thyroid cancer, Hurthle cell 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Rhabdomyosarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Melanoma 1Gastrointestinal Stromal Tumors 1Fibrolamellar hepatocellular carcinoma 1Desmoplastic Small Round Cell Tumor 1Carcinoma 1

Interventions

X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Magnetic Resonance Spectroscopy 5Biopsy 4ulixertinib 2tipifarnib 2selpercatinib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vincristine 2Sorafenib 2Oxaliplatin 2Irinotecan 2Gemcitabine 2Fluorouracil 2Etoposide 2Doxorubicin 2Cisplatin 2Carboplatin 2tazemetostat 1pembrolizumab 1palbociclib 1olaparib 1dostarlimab 1dehydroftorafur 1cabozantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Hepatoblastoma × Sorafenib × Clear all
NCT03017326 2026-05-13

PHITT

University of Birmingham

Phase 3 Active not recruiting
450 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatoblastoma

NCT03533582 2025-12-22

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Children's Oncology Group

Phase 3 Active not recruiting
537 enrolled
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡